Filing Details
- Accession Number:
- 0001179110-12-017723
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-14 19:26:20
- Reporting Period:
- 2012-12-13
- Filing Date:
- 2012-12-14
- Accepted Time:
- 2012-12-14 19:26:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1005201 | Depomed Inc | DEPO | Pharmaceutical Preparations (2834) | 943229046 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1420228 | Md Michael Sweeney | 7999 Gateway Boulevard, Suite 300 Newark CA 94560 | Cmo And Vp, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-12-13 | 40,000 | $1.83 | 45,315 | No | 4 | M | Direct | |
Comon Stock | Disposition | 2012-12-13 | 43,635 | $5.87 | 1,680 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2012-12-13 | 40,000 | $0.00 | 40,000 | $1.83 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
45,000 | 2019-01-23 | No | 4 | M | Direct |
Footnotes
- 85,000 stock options were granted on 1/23/2009 and exercisable in 48 equal monthly installments.
- The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.85 to $5.915. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.